Showing 121 - 140 results of 1,484 for search '(((( algorithm python function ) OR ( algorithm pca function ))) OR ( algorithm brain function ))', query time: 0.75s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128

    Data_Sheet_1_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.PDF by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  9. 129

    Table_4_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.DOCX by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  10. 130

    Table_1_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.DOCX by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  11. 131

    Table_2_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.DOCX by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  12. 132

    Table_5_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.docx by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  13. 133

    Data_Sheet_2_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.PDF by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  14. 134

    Table_3_Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging.DOCX by Josefa Díaz-Álvarez (5572427)

    Published 2022
    “…Genetic algorithms, customized with K-Nearest Neighbor and BayesNet Naives as the fitness function, were developed and compared with Principal Component Analysis (PCA). …”
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139

    Data_Sheet_1_Prediction of motor function in patients with traumatic brain injury using genetic algorithms modified back propagation neural network: a data-based study.docx by Hui Dang (4396087)

    Published 2023
    “…</p>Conclusion<p>The genetic algorithms modified back propagation neural network can predict motor function in patients with traumatic brain injury, which can be used as a reference for risk and prognosis assessment and guide clinical decision-making.…”
  20. 140

    Data_Sheet_1_Prediction of motor function in patients with traumatic brain injury using genetic algorithms modified back propagation neural network: A data-based study.docx by Hui Dang (4396087)

    Published 2023
    “…</p>Conclusion<p>The genetic algorithms modified back propagation neural network can predict motor function in patients with traumatic brain injury, which can be used as a reference for risk and prognosis assessment and guide clinical decision-making.…”